J&J Wins Patent Fight Over Drug Stent

Law360, New York (April 9, 2007, 12:00 AM EDT) -- A drug-eluting stent distributed by a Johnson & Johnson Inc. subsidiary does not infringe on a Boston Scientific Corp. patent for a method of administering drugs to treat heart disease, a Delaware federal court has ruled.

U.S. District Court Judge Sue Robinson ruled in favor of J&J’s motion for summary judgment of noninfringement on April 4, finding that “based on the evidence of record, no reasonable juror could find for BSC on the issue of infringement,” according to the ruling.

Boston Scientific accused J&J’s Cordis Corp....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.